Research ArticleOriginal Article
Open Access
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain and Ahmed M. Maklad
Saudi Medical Journal January 2015, 36 (4) 442-448; DOI: https://doi.org/10.15537/smj.2015.4.10341
Khalid H. Al-Qahtani
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCSCMushabbab Al-Asiri
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBS, FRCSI (Clin Oncol)Mutahir A. Tunio
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBS, FCPS (Rad Oncol)Naji J. Aljohani
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCPCYasser Bayoumi
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBCH, MDHussain Al-Hussain
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCPCAhmed M. Maklad
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBCH, MD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain, Ahmed M. Maklad
Saudi Medical Journal Jan 2015, 36 (4) 442-448; DOI: 10.15537/smj.2015.4.10341
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain, Ahmed M. Maklad
Saudi Medical Journal Jan 2015, 36 (4) 442-448; DOI: 10.15537/smj.2015.4.10341
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.